Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization

Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization

The wet type of age-related macular degeneration (AMD) accompanies the subfoveal choroidal neovascularization (CNV) caused by the abnormal extension or remodeling of blood vessels to the macula and retinal pigment epithelium (RPE). Vascular endothelial growth factor (VEGF) is known to play a crucial...

Full description

Bibliographic Details
Main Authors: E Seul Kim, Min Sang Lee, Hayoung Jeong, Su Yeon Lim, Doha Kim, Dahwun Kim, Jaeback Jung, Siyan Lyu, Hee Joo Cho, Dong Min Kim, Wonhee Suh, Ji Hoon Jeong
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
rivoceranib
drug repositioning
microsphere
subfoveal choroidal neovascularization
macular degeneration
Online Access:https://www.mdpi.com/1999-4923/13/10/1548

Internet

https://www.mdpi.com/1999-4923/13/10/1548

Similar Items